Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

Bullboard (TSXV:RX)

View:
Comment by lscfaon Nov 18, 2021 7:07pm

RE:RE:Very Soldi 3rd Q Results

  Selling/promotion   1,011,274 Q3 21 1,911,896 Q2 21  ...more  
Comment by lscfaon Nov 18, 2021 7:00pm

RE:Very Soldi 3rd Q Results

Looks like the co. took a breather on advertising and promotion in Q3 (almost $1 million lower) but is set to ramp up again.......
Post by overnouton Nov 18, 2021 5:04pm

Very Soldi 3rd Q Results

BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and nine months ended September 30, 2021. Key highlights include: Third quarter (Q3) 2021 Net Revenues ...more  
Post by Possibleidiot01on Sep 29, 2021 2:43pm

jason del vicario - BNN - BUY

BioSyent Inc(RX-X) Licenses existing drugs with a smaller customer base from companies outside NA. Interesting new product that combines Advil and Tylenol in one dose. Market's underestimating ...more  
Post by Possibleidiot01on Aug 31, 2021 6:52am

Raymond James - cantechletter.com

By Geordie Carragher August 30, 2021 Filed under:   All posts Take a pass on BioSyent, says Raymond James After mixed ...more  
Post by overnouton Aug 25, 2021 8:54am

Second Quarter Results

MISSISSAUGA, Ontario, Aug. 25, 2021 (GLOBE NEWSWIRE) --  BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and six months ended ...more  
Comment by lscfaon Jul 13, 2021 10:54am

RE:Anyone care to guess what this is about?

https://www.washington.edu/news/2016/09/07/hemaapp-screens-for-anemia-blood-conditions-without-needle-sticks/
Comment by theinvestor22on Jul 13, 2021 8:53am

RE:Anyone care to guess what this is about?

I mean, I'm assuming it's some sort of app which issues reminders and provides links to relevant info related to iron deficiency management.  Perhaps it is intended to make the company ...more  
Post by theinvestor22on Jul 13, 2021 8:49am

Anyone care to guess what this is about?

BioSyent Signs Exclusive Technology Agreement   MISSISSAUGA, Ontario, July 13, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that its subsidiary, ...more  
Comment by theinvestor22on Jun 24, 2021 1:14pm

RE:Significant Outside Position Announced

It seems this NR has been the catalyst for a price increase.  Not much volume, other than the cross trade referenced in this NR, but the increase is still welcome.  Still way undervalued ...more  
Comment by Possibleidiot01on Jun 18, 2021 7:22pm

RE:Significant Outside Position Announced

You might want to look at the track record of Fax Capital, Good stockpickers imho . They made a lot of money on People Corporation who were bought by Goldman Sachs . Current holdings below - some of ...more  
Post by overnouton Jun 11, 2021 9:21am

Significant Outside Position Announced

TORONTO, June 11, 2021 (GLOBE NEWSWIRE) --  FAX Capital Corp. (FAX or the Company) (TSX: FXC & FXC.WT) is pleased to announce that it has acquired ownership of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities